Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ramelteon versus placebo with zopiclone reference in adults with chronic insomnia
2004-004350-91Phase 3Completed
- Sponsor
- Takeda
- Start
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ramelteon in Insomnia (3 arms), sponsored by Takeda. Primary endpoint: Balance/postural stability with eyes open. Started Jun 2005; status: completed.
02
Drugs
ramelteon
03
Conditions
Insomnia
Beyond the preview
Go deeper on 2004-004350-91.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004350-91.